Tuberculosis and Autoimmunity

Overview

Journal Pathophysiology

Publisher MDPI

Specialty Pathology

Date 2022 Jun 23

PMID 35736650

Authors

Irina V Belyaeva

Anna N Kosova

Andrei G Vasiliev

Affiliations

Soon will be listed here.

Abstract

Tuberculosis remains a common and dangerous chronic bacterial infection worldwide. It is long-established that pathogenesis of many autoimmune diseases is mainly promoted by inadequate immune responses to bacterial agents, among them Mycobacterium tuberculosis. Tuberculosis is a multifaceted process having many different outcomes and complications. Autoimmunity is one of the processes characteristic of tuberculosis; the presence of autoantibodies was documented by a large amount of evidence. The role of autoantibodies in pathogenesis of tuberculosis is not quite clear and widely disputed. They are regarded as: (1) a result of imbalanced immune response being reactive in nature, (2) a critical part of TB pathogenicity, (3) a beginning of autoimmune disease, (4) a protective mechanism helping to eliminate microbes and infected cells, and (5) playing dual role, pathogenic and protective. There is no single autoimmunity-mechanism development in tuberculosis; different pathways may be suggested. It may be excessive cell death and insufficient clearance of dead cells, impaired autophagy, enhanced activation of macrophages and dendritic cells, environmental influences such as vitamin D insufficiency, and genetic polymorphism, both of and host.

Citing Articles

Autoimmune Diseases and Molecular Mimicry in Tuberculosis.

Churilov L, Normatov M, Ling H, Zhuang M, Kudlay D, Starshinova A Biology (Basel). 2025; 13(12.

PMID: 39765749 PMC: 11673594. DOI: 10.3390/biology13121083.

Deletion of Card9 eliminates the detrimental facets of mycobacterial adjuvants.

Mitsuyama H, Iizasa E, Kukita A, Toda S, Yoshida H, Inoue H Heliyon. 2024; 10(19):e38139.

PMID: 39386804 PMC: 11462255. DOI: 10.1016/j.heliyon.2024.e38139.

Long-term follow-up after treatment of tubercular uveitis: case series and review of the literature.

Putera I, van Daele P, Ten Berge J, Dik W, La Distia Nora R, van Hagen P Front Ophthalmol (Lausanne). 2024; 3:1270948.

PMID: 38983011 PMC: 11182287. DOI: 10.3389/fopht.2023.1270948.

Infectious and non-infectious precipitants of sarcoidosis.

Chioma O, Wiggins Z, Rea S, Drake W J Autoimmun. 2024; 149:103239.

PMID: 38821769 PMC: 11607178. DOI: 10.1016/j.jaut.2024.103239.

B cell heterogeneity in human tuberculosis highlights compartment-specific phenotype and functional roles.

Krause R, Ogongo P, Tezera L, Ahmed M, Mbano I, Chambers M Commun Biol. 2024; 7(1):584.

PMID: 38755239 PMC: 11099031. DOI: 10.1038/s42003-024-06282-7.

References

Magna M, Pisetsky D . The Role of Cell Death in the Pathogenesis of SLE: Is Pyroptosis the Missing Link?. Scand J Immunol. 2015; 82(3):218-24. DOI: 10.1111/sji.12335. View

Meena L . An overview to understand the role of PE_PGRS family proteins in Mycobacterium tuberculosis H37 Rv and their potential as new drug targets. Biotechnol Appl Biochem. 2014; 62(2):145-53. DOI: 10.1002/bab.1266. View

Matzinger P, Guerder S . Does T-cell tolerance require a dedicated antigen-presenting cell?. Nature. 1989; 338(6210):74-6. DOI: 10.1038/338074a0. View

Khedkar S, Samad M, Choudhury S, Lee J, Zhang D, Thadhani R . Identification of Novel Non-secosteroidal Vitamin D Receptor Agonists with Potent Cardioprotective Effects and devoid of Hypercalcemia. Sci Rep. 2017; 7(1):8427. PMC: 5559458. DOI: 10.1038/s41598-017-08670-y. View

Ryffel B, Fremond C, Jacobs M, Parida S, Botha T, Schnyder B . Innate immunity to mycobacterial infection in mice: critical role for toll-like receptors. Tuberculosis (Edinb). 2005; 85(5-6):395-405. DOI: 10.1016/j.tube.2005.08.021. View

Mok M . Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus. Int J Rheum Dis. 2015; 18(2):250-9. DOI: 10.1111/1756-185X.12532. View

Farias A, Spagnol G, Bordeaux-Rego P, Oliveira C, Fontana A, de Paula R . Vitamin D3 induces IDO+ tolerogenic DCs and enhances Treg, reducing the severity of EAE. CNS Neurosci Ther. 2013; 19(4):269-77. PMC: 6493393. DOI: 10.1111/cns.12071. View

Cantorna M, Mahon B . Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004; 229(11):1136-42. DOI: 10.1177/153537020422901108. View

Shen C, Hsieh S, Yu C, Wang J, Lee L, Yu C . Autoantibody prevalence in active tuberculosis: reactive or pathognomonic?. BMJ Open. 2013; 3(7). PMC: 3731725. DOI: 10.1136/bmjopen-2013-002665. View

10.

Shao W, Kuan A, Wang C, Abraham V, Waldman M, Vogelgesang A . Disrupted Mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses. J Autoimmun. 2010; 35(4):368-74. PMC: 2963713. DOI: 10.1016/j.jaut.2010.08.001. View

11.

Khader S, Guglani L, Rangel-Moreno J, Gopal R, Junecko B, Fountain J . IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J Immunol. 2011; 187(10):5402-7. PMC: 3208087. DOI: 10.4049/jimmunol.1101377. View

12.

Lee Y, Awasthi A, Yosef N, Quintana F, Xiao S, Peters A . Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012; 13(10):991-9. PMC: 3459594. DOI: 10.1038/ni.2416. View

13.

Peyrin-Biroulet L, Oussalah A, Bigard M . Crohn's disease: the hot hypothesis. Med Hypotheses. 2009; 73(1):94-6. DOI: 10.1016/j.mehy.2009.01.022. View

14.

Steinman R, Idoyaga J . Features of the dendritic cell lineage. Immunol Rev. 2010; 234(1):5-17. DOI: 10.1111/j.0105-2896.2009.00888.x. View

15.

Wallet M, Flores R, Wang Y, Yi Z, Kroger C, Mathews C . MerTK regulates thymic selection of autoreactive T cells. Proc Natl Acad Sci U S A. 2009; 106(12):4810-5. PMC: 2660755. DOI: 10.1073/pnas.0900683106. View

16.

Ferreira G, Vanherwegen A, Eelen G, Gutierrez A, Van Lommel L, Marchal K . Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways. Cell Rep. 2015; 10(5):711-725. DOI: 10.1016/j.celrep.2015.01.013. View

17.

Velez D, Wejse C, Stryjewski M, Abbate E, Hulme W, Myers J . Variants in toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans. Hum Genet. 2009; 127(1):65-73. PMC: 2902366. DOI: 10.1007/s00439-009-0741-7. View

18.

Maione F, Paschalidis N, Mascolo N, Dufton N, Perretti M, DAcquisto F . Interleukin 17 sustains rather than induces inflammation. Biochem Pharmacol. 2008; 77(5):878-87. DOI: 10.1016/j.bcp.2008.11.011. View

19.

Darrasse-Jeze G, Deroubaix S, Mouquet H, Victora G, Eisenreich T, Yao K . Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J Exp Med. 2009; 206(9):1853-62. PMC: 2737156. DOI: 10.1084/jem.20090746. View

20.

Brennan P, Nikaido H . The envelope of mycobacteria. Annu Rev Biochem. 1995; 64:29-63. DOI: 10.1146/annurev.bi.64.070195.000333. View